mStrawberry Polyclonal Antibody

What is mStrawberry and how does it relate to other fluorescent proteins in the RFP family?

mStrawberry is a monomeric variant of red fluorescent protein (RFP) originally derived from the mushroom polyp coral Discosoma sp.. It belongs to the wider family of RFP variants that includes mCherry, tdTomato, mBanana, mOrange, mPlum, and mTangerine. mStrawberry was engineered as part of efforts to develop brighter and more photostable fluorescent proteins with improved properties for research applications.

The relationship between mStrawberry and other RFP variants is important to understand because most commercial polyclonal antibodies raised against RFP or its variants will cross-react with mStrawberry. Specifically, antibodies raised against the full-length amino acid sequence (234aa) of RFP typically recognize epitopes common to multiple RFP variants .

What experimental applications are suitable for mStrawberry Polyclonal Antibody?

mStrawberry Polyclonal Antibody can be used in multiple experimental applications, with varying optimal dilutions:

These applications have been validated across multiple studies, making the antibody versatile for various research contexts .

How specific are mStrawberry Polyclonal Antibodies, and what cross-reactivity should researchers expect?

mStrawberry Polyclonal Antibodies typically recognize multiple RFP variants due to shared epitopes. According to immunoelectrophoresis assays, most commercially available polyclonal antibodies against RFP and its variants show expected reactivity against:

• mStrawberry

• mCherry

• tdTomato

• mBanana

• mPlum

• mOrange

Many commercial antibodies have been pre-adsorbed to remove unwanted reactivities against human, mouse, or rat serum proteins, resulting in minimal background in tissues from these species. ELISA testing confirms specificity with cross-reactivity typically below 0.1% of target signal .

For experiments requiring absolute specificity between RFP variants, researchers should consider the MILKSHAKE validation method, which uses modified maltose-binding protein enzymatically conjugated to target peptides to confirm antibody specificity for particular epitopes .

What is the optimal sample preparation protocol when using mStrawberry Polyclonal Antibody for immunofluorescence?

For optimal immunofluorescence results with mStrawberry Polyclonal Antibody, the following protocol has been validated:

• Fixation: Use 4% paraformaldehyde (PFA) for 2 hours at 4°C for tissue samples or 0.5-4% PFA for 10-15 minutes at room temperature for cultured cells.

• Washing: Perform sequential washes in phosphate buffer (0.1M, pH 7.4) for 1 hour at 4°C.

• Permeabilization: Treat samples with 0.1M TrisHCl (pH 7.4) containing 2% Triton X-100 and 0.5% BSA for 20 minutes at room temperature.

• Antibody incubation: Apply mStrawberry Polyclonal Antibody diluted 1:1000 in permeabilization buffer for 2 hours at room temperature.

• Washing: Wash slides once for 5 minutes in 0.1M TrisHCl (pH 7.4).

• Secondary antibody: Incubate with appropriate fluorophore-conjugated secondary antibody (e.g., donkey anti-rabbit) diluted 1:300 in permeabilization buffer for 2 hours at room temperature.

• Final washing: Wash multiple times with buffer before mounting.

This protocol has been successfully implemented for detecting mStrawberry in transgenic mouse tissues, specifically in thymus samples, with minimal background signal .

How should researchers validate the specificity of mStrawberry Polyclonal Antibody in their experimental system?

Validation of mStrawberry Polyclonal Antibody specificity should follow a multi-step approach:

• Positive and negative controls: Include samples from both wildtype and mStrawberry-expressing tissues/cells. The antibody should show signal only in mStrawberry-expressing samples .

• Secondary antibody control: Test secondary antibody alone on mStrawberry-expressing samples to ensure the observed signal is not due to non-specific binding of the secondary antibody.

• Cross-reactivity assessment: If working in a system with multiple fluorescent proteins, test the antibody against cells expressing other fluorescent proteins to assess cross-reactivity.

• Western blot validation: Perform Western blot analysis to confirm the antibody detects a band of the expected size (~27kDa) in mStrawberry-expressing samples.

• MILKSHAKE method: For advanced validation, consider using the MILKSHAKE method, which employs modified maltose-binding protein enzymatically conjugated to target peptides as a surrogate antigen to confirm antibody specificity .

• Blocking peptide: Use recombinant mStrawberry protein as a competitive inhibitor to confirm signal specificity.

These validation steps ensure experimental results are reliable and specific to mStrawberry.

How can researchers overcome weak or inconsistent mStrawberry signal detection using polyclonal antibodies?

When facing weak or inconsistent mStrawberry signal detection, consider these methodological solutions:

• Optimize fixation conditions: mStrawberry epitopes can be sensitive to overfixation. Test different fixation times (2-24 hours) and paraformaldehyde concentrations (0.5-4%).

• Antigen retrieval: For paraffin-embedded tissues or highly fixed samples, implement antigen retrieval using citrate buffer (pH 6.0) or EDTA buffer (pH 9.0) with heat treatment.

• Signal amplification: Employ tyramide signal amplification (TSA) or use biotinylated secondary antibodies with streptavidin-conjugated fluorophores to enhance signal detection.

• Adjust antibody incubation: Extend primary antibody incubation to overnight at 4°C and optimize antibody concentration through titration experiments (test 1:100 to 1:5000 dilutions).

• Reduce autofluorescence: Treat samples with sodium borohydride (0.1% for 5 minutes) or use commercial autofluorescence quenchers, particularly important for tissues with high intrinsic autofluorescence.

• Blocking optimization: Use a combination of 5-10% normal serum (matching secondary antibody host) with 1% BSA and 0.3% Triton X-100 to reduce background.

These approaches have been successfully implemented in research using mStrawberry in mouse tissues, particularly in lung and embryonic myocardial tissues .

What are the key considerations when using mStrawberry Polyclonal Antibodies in multiplex immunostaining experiments?

For successful multiplex immunostaining with mStrawberry Polyclonal Antibody:

• Antibody compatibility: Select antibodies raised in different host species (e.g., rabbit anti-mStrawberry with mouse anti-GFP) to avoid cross-reactivity between secondary antibodies.

• Spectral overlap management: Choose secondary antibody fluorophores with minimal spectral overlap. For example, pair anti-rabbit Alexa Fluor 647 (for mStrawberry detection) with anti-mouse Alexa Fluor 488 (for other targets).

• Sequential staining protocol: For challenging combinations, employ sequential staining with intermediate fixation steps:

  • Apply first primary antibody → secondary antibody

  • Briefly fix with 2% PFA for 10 minutes

  • Apply second primary antibody → different secondary antibody

• Cross-reactivity prevention: Block between sequential staining steps using excess non-conjugated Fab fragments matching the host of the first secondary antibody.

• Proper controls: Include single-stained controls and fluorescence-minus-one (FMO) controls to accurately set imaging parameters and compensation.

• Order of detection: Begin with the weakest signal and progress to the strongest to prevent signal masking.

This approach has been successful in experiments combining mStrawberry detection with other fluorescent proteins or cellular markers in various tissues .

How should researchers differentiate between endogenous mStrawberry fluorescence and antibody-detected signal in transgenic models?

Distinguishing between direct mStrawberry fluorescence and antibody-mediated detection requires careful experimental design and analysis:

• Spectral imaging: Capture the direct mStrawberry fluorescence (excitation ~574 nm, emission ~596 nm) before antibody staining, then compare with post-staining images.

• Photobleaching assessment: mStrawberry's native fluorescence is susceptible to photobleaching. Document fluorescence before and after intense illumination, as antibody-detected signal will remain more stable.

• Split-sample comparison: Process identical tissue sections with and without antibody staining to quantitatively compare signal patterns and intensities.

• Sequential imaging protocol:
  a. Image native mStrawberry fluorescence
  b. Apply mStrawberry antibody with far-red secondary antibody (e.g., Alexa Fluor 647)
  c. Re-image the same section
  d. Use colocalization analysis to determine signal overlap and unique distributions

• Fixed-cell time course: To distinguish signal sources in fixed samples, prepare a time-course experiment where cells are fixed at different time points after transfection/transduction to correlate direct fluorescence intensity with antibody-detected signal.

This methodological approach has been validated in studies using mStrawberry in mouse myocardial tissue, where countering native red fluorescence with antibody-based blue fluorescence allowed clear distinction between signals .

What statistical approaches are recommended for quantifying mStrawberry antibody signal in tissues with variable expression levels?

For robust quantification of mStrawberry signal across tissues with variable expression:

• Region of Interest (ROI) standardization: Define anatomically consistent ROIs across samples based on tissue morphology rather than signal intensity to avoid selection bias.

• Background subtraction methods: Implement rolling ball algorithm (radius ~50 pixels) for cytoplasmic signals or local background subtraction for nuclear signals.

• Signal normalization strategies:

  • Normalize to total cell count using DAPI or other nuclear markers

  • Use ratio metrics comparing mStrawberry signal to housekeeping protein signal

  • Apply tissue-specific autofluorescence correction factors

• Statistical analysis recommendations:

  Analysis Type	Recommended Test	Application
  Two-group comparison	Mann-Whitney U test	Non-parametric comparison when normal distribution cannot be assumed
  Multiple group comparison	Kruskal-Wallis with Dunn's post-hoc	When comparing multiple experimental conditions
  Correlation analysis	Spearman's rank correlation	For assessing relationship between mStrawberry signal and other variables
  Signal distribution	Kolmogorov-Smirnov test	For comparing histograms of signal intensity distribution

• Machine learning approaches: For tissues with complex cellular composition, implement machine learning-based segmentation and classification to identify positive cells and quantify expression levels.

• Biological replicates: Analyze at least 5-8 biological replicates per condition to account for natural variability in transgene expression.

These quantification approaches have been successfully applied in studies examining mStrawberry expression in complex tissues such as brain and lung .

How do new antibody validation methodologies like MILKSHAKE improve reliability in mStrawberry Polyclonal Antibody research?

The MILKSHAKE validation method represents a significant advancement in antibody validation technology that benefits mStrawberry Polyclonal Antibody research:

• Mechanism: MILKSHAKE uses modified maltose-binding protein enzymatically conjugated to a target peptide to create a surrogate protein that can be used to validate antibody specificity in Western blot applications.

• Advantages for mStrawberry research:

  • Allows validation even in the absence of suitable cell lysates expressing mStrawberry

  • Can confirm specificity for mStrawberry versus other RFP variants by using peptide sequences unique to mStrawberry

  • Provides a consistent, reproducible control that eliminates batch-to-batch variation in validation samples

  • Enables targeted validation of specific epitopes by using defined peptide sequences

• Implementation process:

  • The surrogate protein (MILKSHAKE) containing mStrawberry-specific epitopes is mixed with mammalian cell lysate

  • The mixture is used in Western blot to validate antibody specificity

  • The method serves both as validation and as a Western blot process control

• Impact on reproducibility: MILKSHAKE validation significantly improves the reliability of research by ensuring antibody specificity and consistency, addressing the reproducibility crisis that has been identified as a major concern in the scientific community .

• Future applications: This methodology is evolving toward validating antibodies against post-translationally modified targets and for determining specificity at polymorphic sites, which could benefit research using modified mStrawberry variants.

What are the emerging applications of nanobodies against fluorescent proteins like mStrawberry compared to conventional polyclonal antibodies?

Nanobodies (single-domain antibodies derived from camelid heavy-chain antibodies) represent an emerging technology with distinct advantages over conventional polyclonal antibodies for mStrawberry research:

• Structural and functional advantages:

  • Smaller size (~15 kDa vs. ~150 kDa for conventional antibodies) allowing better tissue penetration

  • Higher stability under varying pH and temperature conditions

  • Ability to recognize epitopes inaccessible to conventional antibodies

  • Reduced immunogenicity in in vivo applications

• Specialized applications with mStrawberry:

  • Super-resolution microscopy: Nanobodies' small size results in reduced linkage error

  • Intracellular expression: Can be expressed as intrabodies to track mStrawberry-tagged proteins in living cells

  • Protein degradation studies: Nanobody-based degrons can target mStrawberry-tagged proteins for proteasomal degradation

• Comparative advantages over polyclonal antibodies:

  Feature	Nanobodies	Polyclonal Antibodies
  Size	~15 kDa	~150 kDa
  Tissue penetration	Superior	Limited
  Production consistency	High	Batch-to-batch variation
  Epitope recognition	Single epitope	Multiple epitopes
  Live-cell applications	Compatible	Limited
  Cost of production	Initially higher	Lower
  Stability	Very high	Moderate

• Future directions: Development of nanobodies specifically targeting unique epitopes of mStrawberry to distinguish it from other RFP variants with greater specificity than currently available polyclonal antibodies .

Nanobody technology is expected to revolutionize research using fluorescent proteins like mStrawberry by enabling more precise targeting, enhanced imaging resolution, and novel functional applications beyond simple detection.